Drug intelligence / Profile preview

radium

Development stage
Discontinued
Lead developer
Bayer
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Topical, Oral, Subcutaneous, Inhalation, Rectal, Intracavitary, Implantation (brachytherapy), External Beam
01

Overview

Radium is a radioactive element discovered by Marie and Pierre Curie in 1898, initially used in medicine for its ability to destroy diseased cells with ionizing radiation. It was employed both directly—applied as radium salts or incorporated into sealed tubes for contact with tissues—and indirectly, through its decay product radon, for various forms of therapy. Mechanistically, radium works by emitting alpha, beta, and gamma radiation, which damages cellular DNA, leading to cell death; this effect was harnessed to treat cancers (especially skin, prostate, and gynecologic cancers) and various non-malignant conditions such as lupus, arthritis, gout, and tuberculosis. Early medical enthusiasm led to widespread, often unregulated use in consumer products and quack medicines; the significant risks (including radiation poisoning, bone fractures, anemia, and increased cancer risk) led to its abandonment for most medical purposes by the mid-20th century in favor of safer radioactive isotopes.

Other names
radium chlorideradium salts
02

Targets

DNA

Beyond the preview

Go deeper on radium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on radium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call